位置:首页 > 蛋白库 > HPSE_BOVIN
HPSE_BOVIN
ID   HPSE_BOVIN              Reviewed;         545 AA.
AC   Q9MYY0;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   03-AUG-2022, entry version 96.
DE   RecName: Full=Heparanase;
DE            EC=3.2.1.166;
DE   Contains:
DE     RecName: Full=Heparanase 8 kDa subunit;
DE   Contains:
DE     RecName: Full=Heparanase 50 kDa subunit;
DE   Flags: Precursor;
GN   Name=HPSE;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=11277877; DOI=10.1530/rep.0.1210573;
RA   Kizaki K., Nakano H., Nakano H., Takahashi T., Imai K., Hashizume K.;
RT   "Expression of heparanase mRNA in bovine placenta during gestation.";
RL   Reproduction 121:573-580(2001).
CC   -!- FUNCTION: Endoglycosidase that cleaves heparan sulfate proteoglycans
CC       (HSPGs) into heparan sulfate side chains and core proteoglycans.
CC       Participates in extracellular matrix (ECM) degradation and remodeling.
CC       Selectively cleaves the linkage between a glucuronic acid unit and an
CC       N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo
CC       group. Can also cleave the linkage between a glucuronic acid unit and
CC       an N-sulfo glucosamine unit carrying a 2-O-sulfo group, but not
CC       linkages between a glucuronic acid unit and a 2-O-sulfated iduronic
CC       acid moiety. Essentially inactive at neutral pH but becomes active
CC       under acidic conditions such as during tumor invasion and in
CC       inflammatory processes. Facilitates cell migration associated with
CC       metastasis, wound healing and inflammation. Enhances shedding of
CC       syndecans. Acts as procoagulant by enhancing the generation of
CC       activated factor X/F10 in the presence of tissue factor/TF and
CC       activated factor VII/F7. Independent of its enzymatic activity,
CC       increases cell adhesion to the extracellular matrix (ECM). Enhances
CC       AKT1/PKB phosphorylation, possibly via interaction with a lipid raft-
CC       resident receptor. Plays a role in the regulation of osteogenesis.
CC       Enhances angiogenesis through up-regulation of SRC-mediated activation
CC       of VEGF. Implicated in hair follicle inner root sheath differentiation
CC       and hair homeostasis (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=endohydrolysis of (1->4)-beta-D-glycosidic bonds of heparan
CC         sulfate chains in heparan sulfate proteoglycan.; EC=3.2.1.166;
CC   -!- ACTIVITY REGULATION: Inhibited by laminarin sulfate and, to a lower
CC       extent, by heparin, sulfamin and EDTA. Activated by calcium and
CC       magnesium (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer; heterodimer formation between the 8 kDa and the
CC       50 kDa subunits is required for enzyme activity (By similarity).
CC       Interacts with TF; the interaction, inhibited by heparin, enhances the
CC       generation of activated factor X and activates coagulation. Interacts
CC       with HRG; the interaction is enhanced at acidic pH, partially inhibits
CC       binding of HPSE to cell surface receptors and modulates its enzymatic
CC       activity. Interacts with SDC1; the interaction enhances the shedding of
CC       SDC1. Interacts with HPSE2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Secreted {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=Proheparanase is secreted via vesicles of the
CC       Golgi. Interacts with cell membrane heparan sulfate proteoglycans
CC       (HSPGs). Endocytosed and accumulates in endosomes. Transferred to
CC       lysosomes where it is proteolytically cleaved to produce the active
CC       enzyme. Under certain stimuli, transferred to the cell surface.
CC       Associates with lipid rafts. Colocalizes with SDC1 in
CC       endosomal/lysosomal vesicles. Accumulates in perinuclear lysosomal
CC       vesicles. Heparin retains proheparanase in the extracellular medium (By
CC       similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta and weakly in the
CC       kidney, lung, spleen and uterus. {ECO:0000269|PubMed:11277877}.
CC   -!- PTM: Proteolytically processed. The cleavage of the 65 kDa form leads
CC       to the generation of a linker peptide, and the 8 kDa and the 50 kDa
CC       products. The active form, the 8/50 kDa heterodimer, is resistant to
CC       degradation. Complete removal of the linker peptide appears to be a
CC       prerequisite to the complete activation of the enzyme (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: N-glycosylated. Glycosylation of the 50 kDa subunit appears to be
CC       essential for its solubility (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 79 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF281160; AAF87301.2; -; mRNA.
DR   RefSeq; NP_776507.1; NM_174082.2.
DR   AlphaFoldDB; Q9MYY0; -.
DR   SMR; Q9MYY0; -.
DR   STRING; 9913.ENSBTAP00000007550; -.
DR   CAZy; GH79; Glycoside Hydrolase Family 79.
DR   PaxDb; Q9MYY0; -.
DR   PRIDE; Q9MYY0; -.
DR   GeneID; 281230; -.
DR   KEGG; bta:281230; -.
DR   CTD; 10855; -.
DR   eggNOG; ENOG502QQST; Eukaryota.
DR   InParanoid; Q9MYY0; -.
DR   OrthoDB; 1132327at2759; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030305; F:heparanase activity; ISS:UniProtKB.
DR   GO; GO:0060055; P:angiogenesis involved in wound healing; IBA:GO_Central.
DR   GO; GO:0007160; P:cell-matrix adhesion; IBA:GO_Central.
DR   GO; GO:0030200; P:heparan sulfate proteoglycan catabolic process; ISS:UniProtKB.
DR   InterPro; IPR005199; Glyco_hydro_79.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   Pfam; PF03662; Glyco_hydro_79n; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell adhesion; Disulfide bond; Glycoprotein; Hydrolase; Lysosome;
KW   Magnesium; Membrane; Nucleus; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000250"
FT   CHAIN           38..111
FT                   /note="Heparanase 8 kDa subunit"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000042256"
FT   PROPEP          112..159
FT                   /note="Linker peptide"
FT                   /id="PRO_0000042257"
FT   CHAIN           160..545
FT                   /note="Heparanase 50 kDa subunit"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000042258"
FT   REGION          290..419
FT                   /note="Required for heterodimerization with the heparanase
FT                   8 kDa subunit"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   REGION          529..545
FT                   /note="Required for transferring proheparanase to the Golgi
FT                   apparatus, secretion and subsequent enzyme activity and for
FT                   enhancement of PKB/AKT1 phosphorylation"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   ACT_SITE        227
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   ACT_SITE        345
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         64..66
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         160..164
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         272..282
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         298
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         305
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         350..352
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         391..393
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        219
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        461
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   DISULFID        129..181
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   DISULFID        439..544
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
SQ   SEQUENCE   545 AA;  61077 MW;  FAC4BDFFD855B933 CRC64;
     MLACRKPGLR PPLLLLLPLL GPLGPCSPGT PAAAAPADDA AELEFFTERP LHLVSPAFLS
     FTIDANLATD PRFFTFLGSS KLRTLARGLA PAYLRFGGNK GDFLIFDPKK EPAFEERSYW
     LSQSNQDICK SGSIPSDVEE KLRLEWPFQE QVLLREQYQK KFTNSTYSRS SVDMLYTFAS
     CSGLNLIFGV NALLRTTDMH WDSSNAQLLL DYCSSKNYNI SWELGNEPNS FQRKAGIFIN
     GRQLGEDFIE FRKLLGKSAF KNAKLYGPDI GQPRRNTVKM LKSFLKAGGE VIDSVTWHHY
     YVNGRIATKE DFLNPDILDT FISSVQKTLR IVEKIRPLKK VWLGETSSAF GGGAPFLSNT
     FAAGFMWLDK LGLSARMGIE VVMRQVLFGA GNYHLVDGNF EPLPDYWLSL LFKKLVGNKV
     LMASVKGPDR SKFRVYLHCT NTKHPRYKEG DLTLYALNLH NVTKHLELPH HLFNKQVDKY
     LIKPSGTDGL LSKSVQLNGQ ILKMVDEQTL PALTEKPLHP GSSLGMPPFS YGFFVIRNAK
     VAACI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024